Drug · DIN 00512559
HALCION
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 2, 2006; first marketed December 31, 1980.
- Drug Identification Number (DIN)
- 00512559
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Targeted substances (cdsa iv)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Triazolam N05CD05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRIAZOLAM | 0.125 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 22, 2003: NOC 3598New Drug Submission (NDS) · Manufacturer name change
- May 11, 2001: NOC 2643New Drug Submission (NDS) · Change in manufacturer name
- July 14, 1997: NOC 4166New Drug Submission (NDS)
Other DINs named HALCION
- DIN 00443158 · Cancelled Post Market